MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 235 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $111 | -17.2% | 15,511 | 0.0% | 0.00% | -100.0% |
| Q1 2024 | $134 | +31.4% | 15,511 | 0.0% | 0.00% | – |
| Q4 2023 | $102 | -66.9% | 15,511 | -23.1% | 0.00% | -100.0% |
| Q3 2023 | $308 | +59.6% | 20,178 | +30.1% | 0.00% | 0.0% |
| Q2 2023 | $193 | -11.1% | 15,511 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $217 | -2.3% | 15,511 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $222 | -99.9% | 15,511 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $396,000 | -10.2% | 15,511 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $441,000 | -19.4% | 15,511 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $547,000 | -27.7% | 15,511 | -14.1% | 0.00% | -33.3% |
| Q4 2021 | $757,000 | -14.7% | 18,067 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $887,000 | +17.6% | 18,067 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $754,000 | – | 18,067 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $269,495,240 | 12.63% |
| 12 West Capital Management LP | 3,361,836 | $41,787,621 | 3.59% |
| Alpine Peaks Capital, LP | 329,424 | $4,094,740 | 2.87% |
| Roubaix Capital, LLC | 235,480 | $2,927,016 | 2.15% |
| Prosight Management, LP | 628,600 | $7,813,498 | 1.17% |
| Cannon Global Investment Management, LLC | 15,800 | $196,394 | 1.02% |
| Curi Wealth Management, LLC | 566,417 | $7,040,564 | 0.95% |
| Mesirow Institutional Investment Management, Inc. | 693,376 | $8,618,664 | 0.89% |
| BRAIDWELL LP | 1,804,700 | $22,432,421 | 0.73% |
| Connacht Asset Management LP | 39,031 | $485,155 | 0.66% |